REQUEST A DEMO
Total
USD $0.00
Search more companies

D.O.O. Medicon Dec (Serbia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Machinery, Equipment, and Supplies Merchant Wholesalers | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: D.O.O. Medicon Dec Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Medicon in a private company founded in 1995. The enterprise is primarily engaged in the manufacture and distribution of pharmaceutical products and medical equipment and instruments. It is the exclusive dealer of Gambro and CaridianBCT for Serbia.

Headquarters
Vojvodjanska 97
Dec; Pecinci; Postal Code: www.medicom.rs

Contact Details: Purchase the D.O.O. Medicon Dec report to view the information.

Website: http://CUBE_PROFILES_YU

Basic Information
Total Employees:
Purchase the D.O.O. Medicon Dec report to view the information.
Outstanding Shares:
Purchase the D.O.O. Medicon Dec report to view the information.
Registered Capital:
Purchase the D.O.O. Medicon Dec report to view the information.
Financial Auditors:
Purchase the D.O.O. Medicon Dec report to view the information.
Incorporation Date:
March 04, 1992
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after D.O.O. Medicon Dec report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
11.36%
Total operating revenue
11.82%
Operating profit (EBIT)
132.71%
EBITDA
52.72%
Net Profit (Loss) for the Period
15.95%
Total assets
1.86%
Total equity
3.67%
Operating Profit Margin (ROS)
3.49%
Net Profit Margin
0.13%
Return on Equity (ROE)
0.45%
Debt to Equity Ratio
-0.1%
Quick Ratio
-0.01%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?